Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sure. The What ifs. BUT WHAT IF THE CEO HAD BETTER VISION? Not! DOWLING has no vision that’s why we’re in this rut. He is now indefensible. Must go.
Strongly agree that Dowling oughtta go.NOW.
Doesn’t change the fact that MAJOR CHANGES need to happen. There’s already shareholder exhaustion.
ADAA:Cbd helps reduce severe anxiety & symptoms (Anxiety & Depression Association of America annual conference, 3/18/2021)
It’s fair to say that many of us gave Dowling our vote of confidence, in spite of. But he has not delivered. TIME TO GO.
DOWLING: It’s always everyone else’s fault.
Dowling should go. NO VISION. It’s time for a change.
Milestone 1st steps! Will NYC be looking for GRAS certification?
Great response!
Totally agree with SL. CVSI is cleaning house by terminating the Mona Agreement for “cause” as stipulated in the Agreement.
Definitely a move in the Right Direction.
FInally, in the right direction. Better late than never.
“A Massive Swing in Sentiment” latest publication by New Cannabis Ventures describing Optimism surrounding state-legal programs and potential improvements in federal policy.
Agree that the FDA will be the catalyst.
Yes, C A N T I N E
An OTC smoking cessation drug without nicotine makes it more accessible & tolerable to the general public. Afterall, there are already 2 Rx drugs for smoking cessation that are beyond reach & poorly tolerated by the common folk: zyban & chantix. CVSI just needs to sleep with Big Pharma.
I like the idea of Big Pharma in the mix.
THAT could be the game changer.Noramco/Purisys makes the pharmaceutical grade CBD with <0.001% THc that the FDA was looking for (vs the usual <0.3% THc content that was set as a limit in the 2018 Farm Bill for consumer use).
Smart move by CVSI.
Both Zyban & Chantix are inaccessible to the general public due to cost & side effects.With the new FDA Commissioner acknowledging the current popular use of CBD Oil, and with more people wanting to quit smoking because of the coronavirus, CVSI’s nicotine patent becomes more relevant. It is novel, useful & safe = patent & marketability.
Portal.uspto.gov/Pair/PublicPair 15/426617
NFW!!!!!
CVSI’s got all its ducks in a row,just waiting for FDA regulations this year,and off with go.
Good riddance, indeed!
Agree, the Mona’s are O U T. History.
I will only trust PlusCBDoil.Two years in a row, no liver or kidney issues in my lab results.
Why We Win!!! (This is a Must-Hear if you are a CVSI investor.)
Agree. In the end,it’s large part due to the Mona’s & their (ill)reputation. Now that the Mona’s are G O N E by year start, happy days are here again.
...as US hemp (note: NOT cannabis) growers are getting stronger & united!https://www.google.com/amp/s/www.croplife.com/management/farmers-unite-to-launch-u-s-hemp-growers-association/%3famp
It’s time to distinguish the two.
Counting the days the MONAs will be g o n e!
They have a product that works.Expanding product line. Mona’s g o n e by year start.This is just temporary pain.Buy when sentiment is down.
Yes, works like a charm on anxiety & pain.
CVSI has a product that works. Uncontroverted.That should give any investor pause.
Didn’t someone post that the last of the Mona’s is O U T by year start?
The Lotion is excellent for generalized body itch.
Agree.Temporary hard times.No selling,No loss realized.
Mona G O N E is a good sign.This is what the SEC has been waiting for all along.
Dowling: 3 new BOD to boost NASDAQ uplist!
It’s a convincing website.The testimonials do help a lot.
Stem cell treatment has been & will always be controversial.
That’s 2017.Any recent filing of the PATENT?